Quick Answer
ATOSSA THERAPEUTICS, INC. reported Operating Income of -$37.14 million for fiscal year 2025.
ATOSSA THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$37.14M | -34.5% |
| 2024 | -$27.62M | +12.0% |
| 2023 | -$31.38M | -13.3% |
| 2022 | -$27.69M | -34.9% |
| 2021 | -$20.52M | -40.5% |
| 2020 | -$14.61M | +15.4% |
| 2019 | -$17.27M | -51.0% |
| 2018 | -$11.43M | -49.5% |
| 2017 | -$7.65M | +4.0% |
| 2016 | -$7.97M | +37.5% |
| 2015 | -$12.76M | -4.8% |
| 2014 | -$12.17M | -12.9% |
| 2013 | -$10.78M | -112.8% |
| 2012 | -$5.07M | -47.8% |
| 2011 | -$3.43M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.25M | -44.9% | -2.3% |
| June 30, 2025 | -$9.04M | -27.2% | -21.9% |
| March 31, 2025 | -$7.41M | -6.2% | -16.1% |
| September 30, 2024 | -$6.38M | +14.5% | +10.1% |
| June 30, 2024 | -$7.11M | +8.8% | -1.8% |
| March 31, 2024 | -$6.98M | +1.7% | +6.5% |
| September 30, 2023 | -$7.47M | +9.0% | +4.2% |
| June 30, 2023 | -$7.79M | -18.2% | -9.8% |
- ATOSSA THERAPEUTICS, INC. showed a decrease of -34.5% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, ATOSSA THERAPEUTICS, INC.’s operating income has declined by 983.1% (from -$3.43 million to -$37.14 million).
- The most recent figure is from ATOSSA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: